© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
July 30, 2021
Research showed that the second dose of the COVID-19 vaccine was well tolerated by patients who experienced allergic reactions from their first dose.
The FDA approved selexipag tablets for PAH in 2015.
Studies are needed to determine the best treatment regimen for these patients.
Black patients received different opioid prescriptions compared to White patients, even after clinicians were given additional patient-level data.
July 29, 2021
The FDA noted the extent of the treatment effect of tenapanor is of unclear clinical significance, despite evidence of efficacy.
The biologic can now be used as an add-on maintenance treatment for patients who have struggled with former treatment and surgeries.
Researchers note the severity of the disease significantly impacts patients’ sleep habits, medication intake, and general mental and physical health.
Higher microbiome α diversity had an association with less T2D and lower insulin resistance in individuals without diabetes.
OnabotulinumtoxinA treatment may now include 8 new muscles.
Data show no clinically meaningful difference between insulin glargine-yfgn and insulin glargine in matters of safety, purity and potency.